Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Coivas vs CoraDoc

Coivas
Graded #194

Lower grade

vs+10.599999999999994
CoraDoc
Graded #49

Higher grade

The verdict

CoraDoc takes it — 76.8/100 to 66.2/100.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc is a nationwide (all 50 states) doctor-prescribed GLP-1 weight-loss telehealth service offering compounded semaglutide (from $99/mo) and tirzepatide (from $165/mo) as flat, no-subscription programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoraDoc +26
70
96
Dose & formulationCoraDoc +8
64
72
Clinical oversightCoivas +5
84
79
Labs & monitoringCoivas +1
54
53
FulfillmentCoivas +2
78
76
Contract termsCoraDoc +49
20
69
Coivas · left barCoraDoc · right bar

The numbers

MetricCoivasCoraDoc
WeighScore66.2/10076.8/100
GradeCC
Scorecard rank#194#49
Semaglutide$149/mo (quarterly plan, compounded)$99/mo (all doses, compounded)
Tirzepatide$229/mo (quarterly plan, compounded)$165/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Coivas

Graded #194 · C

Strengths

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Where it loses points

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
CoraDoc

Graded #49 · C

Strengths

  • Low flat pricing — compounded semaglutide from $99/mo, tirzepatide from $165/mo, no subscription
  • Triple Free Promise: free provider visit, free 2-day shipping, and free supplies included
  • Available in all 50 states; HSA/FSA plus Afterpay/Klarna/Affirm; full refund if not approved
  • Full legal suite published (Terms, Privacy, Refund Policy); board-certified providers

Where it loses points

  • Lowest $99 price is the longest-commitment tier (programs range about $99-$199/mo)
  • Compounding pharmacy partner not named
  • 'LegitScript Certified' is stated prominently but was not independently verified here
  • Operating legal entity not clearly named on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard